Tissue Inhibitor of Metalloproteinase (TIMP)-1: the TIMPed Balance of Matrix Metalloproteinases in the Central Nervous System

Overview

Journal J Neurosci Res

Specialty Neurology

Date 2003 Dec 4

PMID 14648584

Citations 90

Authors

Jessica Gardner

Anuja Ghorpade

Affiliations

Soon will be listed here.

Abstract

Astrocytes are intimately involved in the mechanisms of neural injury and repair. They participate in a variety of homeostatic functions and elicit repair responses as balance mechanisms. Currently, there is a growing appreciation of a more active role of astrocytes in neuronal signaling and function. One key homeostatic mechanism of astrocytes in tissue repair is maintained through their production of tissue inhibitors of metalloproteinases (TIMPs). The family of TIMPs (1-4) plays a central regulatory role as inhibitors of matrix metalloproteinases (MMPs), enzymes involved in extracellular matrix maintenance and remodeling. Recently, TIMP-1, the inducible form, has been identified as a multifunctional molecule with divergent functions. It participates in wound healing and regeneration, cell morphology and survival, tumor metastasis, angiogenesis, and inflammatory responses. An imbalance of MMP/TIMP regulation has been implicated in several inflammatory diseases of the central nervous system (CNS). Here we review the conundrums of TIMP-1 regulation in CNS pathophysiology. We propose that astrocyte-TIMP-1 may play an important role in CNS homeostasis and disease. Astrocyte TIMP-1 expression is differentially regulated in inflammatory neurodegenerative diseases and may have significant therapeutic relevance.

Citing Articles

Quercetin triggers cell apoptosis-associated ROS-mediated cell death and induces S and G2/M-phase cell cycle arrest in KON oral cancer cells.

Tubtimsri S, Chuenbarn T, Manmuan S BMC Complement Med Ther. 2025; 25(1):34.

PMID: 39885507 PMC: 11780952. DOI: 10.1186/s12906-025-04782-5.

Human platelet lysate: a potential therapeutic for intracerebral hemorrhage.

Qiu D, Wang L, Wang L, Dong Y Front Neurosci. 2025; 18:1517601.

PMID: 39881806 PMC: 11774881. DOI: 10.3389/fnins.2024.1517601.

The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review.

Nakhal M, Yassin L, Alyaqoubi R, Saeed S, Alderei A, Alhammadi A Life (Basel). 2024; 14(10).

PMID: 39459534 PMC: 11508655. DOI: 10.3390/life14101234.

Molecular changes in intraocular fluid: implications for myopia.

Zhang Z, Lv L, Chen D, Li F, Zhou J Int J Biol Sci. 2024; 20(13):5330-5342.

PMID: 39430251 PMC: 11489174. DOI: 10.7150/ijbs.101438.

Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance.

Tataranu L, Turliuc S, Kamel A, Rizea R, Dricu A, Staicu G Curr Issues Mol Biol. 2024; 46(9):9881-9894.

PMID: 39329940 PMC: 11430601. DOI: 10.3390/cimb46090588.

References

Nguyen M, Arkell J, Jackson C . Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol. 2001; 33(10):960-70. DOI: 10.1016/s1357-2725(01)00007-3. View

Norenberg M . Astrocyte responses to CNS injury. J Neuropathol Exp Neurol. 1994; 53(3):213-20. DOI: 10.1097/00005072-199405000-00001. View

Mannello F, Gazzanelli G . Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis. 2001; 6(6):479-82. DOI: 10.1023/a:1012493808790. View

VanMeter T, Rooprai H, Kibble M, Fillmore H, Broaddus W, Pilkington G . The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol. 2001; 53(2):213-35. DOI: 10.1023/a:1012280925031. View

Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk A, Miller K . Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci. 2002; 15(1):19-32. DOI: 10.1046/j.0953-816x.2001.01838.x. View

Murphy F, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur M . Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem. 2002; 277(13):11069-76. DOI: 10.1074/jbc.M111490200. View

Brand K . Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr Gene Ther. 2002; 2(2):255-71. DOI: 10.2174/1566523024605564. View

Zechel J, Gohil H, Lust W, Cohen A . Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus. J Neurosci Res. 2002; 69(5):662-8. DOI: 10.1002/jnr.10326. View

Takahashi M, Fukami S, Iwata N, Inoue K, Itohara S, Itoh H . In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture. Pharmacol Res. 2002; 46(2):155-63. DOI: 10.1016/s1043-6618(02)00081-6. View

10.

Yang E, Bane C, MacCallum R, Kiecolt-Glaser J, Malarkey W, Glaser R . Stress-related modulation of matrix metalloproteinase expression. J Neuroimmunol. 2002; 133(1-2):144-50. DOI: 10.1016/s0165-5728(02)00270-9. View

11.

Lorenzl S, Albers D, Narr S, Chirichigno J, Beal M . Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Exp Neurol. 2002; 178(1):13-20. DOI: 10.1006/exnr.2002.8019. View

12.

Tan H, Heywood D, Ralph G, Bienemann A, Baker A, Uney J . Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci. 2003; 22(1):98-106. DOI: 10.1016/s1044-7431(02)00024-6. View

13.

Ghorpade A, Nukuna A, Che M, Haggerty S, Persidsky Y, Carter E . Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol. 1998; 72(4):3340-50. PMC: 109814. DOI: 10.1128/JVI.72.4.3340-3350.1998. View

14.

Zhao W, Li H, Yamashita K, Guo X, Hoshino T, Yoshida S . Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci. 1998; 111 ( Pt 9):1147-53. DOI: 10.1242/jcs.111.9.1147. View

15.

Guedez L, Stetler-Stevenson W, Wolff L, Wang J, Fukushima P, Mansoor A . In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest. 1998; 102(11):2002-10. PMC: 509153. DOI: 10.1172/JCI2881. View

16.

Ritter L, Garfield S, Thorgeirsson U . Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem Biophys Res Commun. 1999; 257(2):494-9. DOI: 10.1006/bbrc.1999.0408. View

17.

Bugno M, Witek B, Bereta J, Bereta M, Edwards D, Kordula T . Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett. 1999; 448(1):9-14. DOI: 10.1016/s0014-5793(99)00323-3. View

18.

Kleiner D, Stetler-Stevenson W . Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 1999; 43 Suppl:S42-51. DOI: 10.1007/s002800051097. View

19.

Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T . Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg. 1994; 81(1):69-77. DOI: 10.3171/jns.1994.81.1.0069. View

20.

Dhawan S, Weeks B, Soderland C, Schnaper H, Toro L, Asthana S . HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol. 1995; 154(1):422-32. View